[{"address1": "321 Harrison Avenue", "address2": "5th floor", "city": "Boston", "state": "MA", "zip": "02118", "country": "United States", "phone": "617 213 5054", "website": "https://www.hillevax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 90, "companyOfficers": [{"maxAge": 1, "name": "Dr. Robert M. Hershberg M.D., Ph.D.", "age": 61, "title": "Co-Founder, President, CEO & Chairman of the Board", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 1035100, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Aditya  Kohli Ph.D.", "age": 35, "title": "Co-Founder, Chief Business Officer & Director", "yearBorn": 1988, "fiscalYear": 2023, "totalPay": 765871, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Astrid  Borkowski M.D., Ph.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 854560, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shane A. Maltbie", "age": 41, "title": "CFO & Treasurer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sean  McLoughlin", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anju  Chatterji Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul S. Bavier J.D.", "age": 51, "title": "General Counsel, Secretary & Chief Administrative Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ozzie  Berger", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1717200000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 13.07, "open": 12.92, "dayLow": 12.45, "dayHigh": 13.23, "regularMarketPreviousClose": 13.07, "regularMarketOpen": 12.92, "regularMarketDayLow": 12.45, "regularMarketDayHigh": 13.23, "beta": 0.727, "forwardPE": -4.074766, "volume": 130710, "regularMarketVolume": 130710, "averageVolume": 182654, "averageVolume10days": 180500, "averageDailyVolume10Day": 180500, "bid": 12.94, "ask": 13.09, "bidSize": 100, "askSize": 100, "marketCap": 650349376, "fiftyTwoWeekLow": 9.94, "fiftyTwoWeekHigh": 20.22, "fiftyDayAverage": 13.5118, "twoHundredDayAverage": 14.275375, "currency": "USD", "enterpriseValue": 399541152, "floatShares": 21038178, "sharesOutstanding": 49720900, "sharesShort": 1348054, "sharesShortPriorMonth": 578806, "sharesShortPreviousMonthDate": 1714435200, "dateShortInterest": 1717113600, "sharesPercentSharesOut": 0.0271, "heldPercentInsiders": 0.17139, "heldPercentInstitutions": 0.81365997, "shortRatio": 6.97, "shortPercentOfFloat": 0.17459999, "impliedSharesOutstanding": 49720900, "bookValue": 5.033, "priceToBook": 2.5988476, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -143506000, "trailingEps": -3.3, "forwardEps": -3.21, "enterpriseToEbitda": -2.905, "52WeekChange": -0.2106216, "SandP52WeekChange": 0.24598539, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "HLVX", "underlyingSymbol": "HLVX", "shortName": "HilleVax, Inc.", "longName": "HilleVax, Inc.", "firstTradeDateEpochUtc": 1651239000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ad85351d-ccca-3533-9e30-baa1f712efa8", "messageBoardId": "finmb_1680788968", "gmtOffSetMilliseconds": -14400000, "currentPrice": 13.08, "targetHighPrice": 34.0, "targetLowPrice": 28.0, "targetMeanPrice": 31.0, "targetMedianPrice": 31.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 272743008, "totalCashPerShare": 5.745, "ebitda": -137524000, "totalDebt": 51308000, "quickRatio": 10.592, "currentRatio": 10.917, "debtToEquity": 21.476, "returnOnAssets": -0.28217, "returnOnEquity": -0.5955, "freeCashflow": -86967000, "operatingCashflow": -103831000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-27"}]